These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Mode of action of new antitumor compounds].
    Author: Zaera E, Santamaría F, Zalacaín M, Jiménez A.
    Journal: Rev Esp Oncol; 1982; 29(4):587-92. PubMed ID: 6927363.
    Abstract:
    The antitumoral agents PR toxin, bouvardin and grandilactones A and B inhibit the growth of HeLa cells, and abolish polyphenylaline synthesis by polyuridylic acid in acellular eukaryotic systemns. However, only bouvardin and the PR toxin inhibit polypeptide synthesis in polysomes using endogenous m-RNA. In addition, grandilactones A and B inhibit the "fragment" reaction, which indicates that they affect specifically peptide bond formation, and the lack of effect on polysomes of these compounds would be due to the fact that, in polysomes, the substrate is bound to either the donor on the acceptor site. Apparently, the PR toxin acts by blocking the enzymatic binding to 80 S ribosomes of (3H)phenylalanyl-tRNA. The inhibitory action of bouvardin seems to be result of the selective blocking of peptidyl-tRNA translocation dependent on elongation factor EF-2 and GTP.
    [Abstract] [Full Text] [Related] [New Search]